title: Molecular analysis of HLA-DQB1 alleles in childhood common acute lymphoblastic leukaemia.
abstract: Epidemiological studies suggest that childhood common acute lymphoblastic leukaemia (c-ALL) may be the rare outcome of early post-natal infection with a common infectious agent. One of the factors that may determine whether a child succumbs to c-ALL is how it responds to the candidate infection. Since immune responses to infection are under the partial control of (human leucocyte antigen) HLA genes, an association between an HLA allele and c-ALL could provide support for an infectious aetiology. To define the limit of c-ALL susceptibility within the HLA region, we have compared HLA-DQB1 allele frequencies in a cohort of 62 children with c-ALL with 76 newborn controls, using group-specific polymerase chain reaction (PCR) amplification, and single-strand conformation polymorphism (SSCP) analysis. We find that a significant excess of children with c-ALL type for DQB1*05 [relative risk (RR): 2.54, uncorrected P=0.038], and a marginal excess with DQB1*0501 (RR: 2.18; P=0.095). Only 3 of the 62 children with c-ALL have the other susceptibility allele, DPB1*0201 as well as DQB1*0501, whereas 15 had one or the other allele. This suggests that HLA-associated susceptibility may be determined independently by at least two loci, and is not due to linkage disequilibrium. The combined relative risk of the two groups of children with DPB1*0201 and/or DQB1*0501 is 2.76 (P=0.0076). Analysis of amino acids encoded by exon 2 of DQB1 reveal additional complexity, with significant (P<0.05) or borderline-significant increases in Gly26, His30, Val57, Glu66-Val67 encoding motifs in c-ALL compared with controls. Since these amino acids are not restricted to DQB1*0501, our results suggest that, as with DPB1, the increased risk of c-ALL associated with DQB1 is determined by specific amino acid encoding motifs rather than by an individual allele. These results also suggest that HLA-associated susceptibility to c-ALL may not be restricted to the region bounded by DPB1 and DQB1.
authors.affiliation: Immunogenetics Laboratory, St Mary's Hospital, Manchester, UK.
authors.forename: S P
authors.initials: SP
authors.lastname: Dearden
authors.forename: G M
authors.initials: GM
authors.lastname: Taylor
authors.forename: D A
authors.initials: DA
authors.lastname: Gokhale
authors.forename: M D
authors.initials: MD
authors.lastname: Robinson
authors.forename: W
authors.initials: W
authors.lastname: Thompson
authors.forename: W
authors.initials: W
authors.lastname: Ollier
authors.forename: A
authors.initials: A
authors.lastname: Binchy
authors.forename: J M
authors.initials: JM
authors.lastname: Birch
authors.forename: R F
authors.initials: RF
authors.lastname: Stevens
authors.forename: T
authors.initials: T
authors.lastname: Carr
authors.forename: W G
authors.initials: WG
authors.lastname: Bardsley
mesh_terms: D000483:Alleles; D001483:Base Sequence; D002648:Child; D006683:HLA-DQ Antigens / Q000235:genetics*; D059866:HLA-DQ beta-Chains; D006801:Humans; D007231:Infant, Newborn; D008969:Molecular Sequence Data; D018807:Polymorphism, Single-Stranded Conformational; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics / Q000276:immunology*
chemical_list: D006683:HLA-DQ Antigens; D059866:HLA-DQ beta-Chains; C069051:HLA-DQB1 antigen